These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Ventricular tachycardia and ventricular fibrillation. Srivathsan K; Ng DW; Mookadam F Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):801-9. PubMed ID: 19589116 [TBL] [Abstract][Full Text] [Related]
25. [The Wearable Cardioverter Defibrillator (WCD) for the prevention of sudden cardiac death -- a single center experience]. Reek S; Meltendorf U; Geller JC; Wollbrück A; Grund S; Klein HU Z Kardiol; 2002 Dec; 91(12):1044-52. PubMed ID: 12490994 [TBL] [Abstract][Full Text] [Related]
26. Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population. Obeyesekere MN; Chan W; Stub D; Prabhu S; Teo EP; Toogood G; Mariani J; Broughton A; Kistler PM Pacing Clin Electrophysiol; 2010 Jun; 33(6):696-704. PubMed ID: 20059719 [TBL] [Abstract][Full Text] [Related]
27. [Implantable cardioverter defibrillators in pediatric patients: results in a series of 33 cases]. Tisserant A; Sadoul N; Kouakam C; Kacet S; Rey C; Chauvin M; Lévy J; Mabo P; Marçon F Arch Mal Coeur Vaiss; 2006 May; 99(5):433-8. PubMed ID: 16802731 [TBL] [Abstract][Full Text] [Related]
28. A single implantable cardioverter-defibrillator shock unmasking an electrical storm of 389 ventricular tachycardia episodes triggering device therapies. Arias MA; Valverde I; Puchol A; Castellanos E; Rodríguez-Padial L; Sánchez AM; Alvarez-Temiño M; Palomino M Am J Emerg Med; 2008 Nov; 26(9):1066.e1-3. PubMed ID: 19091283 [TBL] [Abstract][Full Text] [Related]
29. Implantable cardioverter defibrillator therapy: ten years experience in a medical center. Chen TE; Wang CC; Chang SH; Yeh SJ; Wu D Chang Gung Med J; 2008; 31(1):81-90. PubMed ID: 18419057 [TBL] [Abstract][Full Text] [Related]
30. [Implantable cardioverter-defibrillators in patients resuscitated from sudden death and in patients with sustained refractory ventricular tachycardia]. Adragão P; Parreira L; Neves J; Morgado F; Abecassis M; Almeida M; Martins D; Bonhorst D; Seabra-Gomes R Rev Port Cardiol; 1996 Mar; 15(3):195-206, 179, 181. PubMed ID: 8634168 [TBL] [Abstract][Full Text] [Related]
31. Electrical storm in idiopathic ventricular fibrillation is associated with early repolarization. Aizawa Y; Chinushi M; Hasegawa K; Naiki N; Horie M; Kaneko Y; Kurabayashi M; Ito S; Imaizumi T; Aizawa Y; Takatsuki S; Joo K; Sato M; Ebe K; Hosaka Y; Haissaguerre M; Fukuda K J Am Coll Cardiol; 2013 Sep; 62(11):1015-9. PubMed ID: 23747791 [TBL] [Abstract][Full Text] [Related]
32. Predictors of electrical storm recurrences in patients with implantable cardioverter-defibrillators. Streitner F; Kuschyk J; Veltmann C; Mahl E; Dietrich C; Schimpf R; Doesch C; Streitner I; Wolpert C; Borggrefe M Europace; 2011 May; 13(5):668-74. PubMed ID: 21156679 [TBL] [Abstract][Full Text] [Related]
33. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS). Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454 [TBL] [Abstract][Full Text] [Related]
34. Implantable cardioverter-defibrillator therapy for prevention of sudden cardiac death. Akhtar M; Jazayeri MR; Sra JS; Dhala A; Deshpande S; Blanck Z; Axtell K Cardiol Clin; 1993 Feb; 11(1):97-108. PubMed ID: 8435827 [TBL] [Abstract][Full Text] [Related]
36. Implantable cardioverter defibrillator therapy for prevention of sudden cardiac death in children in the Netherlands. Heersche JH; Blom NA; van de Heuvel F; Blank C; Reimer AG; Clur SA; Witsenburg M; ten Harkel AD Pacing Clin Electrophysiol; 2010 Feb; 33(2):179-85. PubMed ID: 20025697 [TBL] [Abstract][Full Text] [Related]
37. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK; J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248 [TBL] [Abstract][Full Text] [Related]
38. QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators. Buxton AE; Sweeney MO; Wathen MS; Josephson ME; Otterness MF; Hogan-Miller E; Stark AJ; Degroot PJ; J Am Coll Cardiol; 2005 Jul; 46(2):310-6. PubMed ID: 16022960 [TBL] [Abstract][Full Text] [Related]
39. [Long-term results of implantable automatic defibrillator in 43 patients. Analysis of predictive factors of the first electric shock]. Chevalier P; Kirkorian G; Desseigne P; Atallah G; Champagnac D; Canu G; Claudel JP; Lacet C; Touboul P Arch Mal Coeur Vaiss; 1993 Oct; 86(10):1459-64. PubMed ID: 8010844 [TBL] [Abstract][Full Text] [Related]
40. [Initial clinical results with a novel implantable cardioverter-defibrillator: a prospective evaluation in 3 Swiss university hospitals]. Osswald S; Candinas R; Fuhrer J Schweiz Med Wochenschr; 1995 Dec; 125(50):2423-32. PubMed ID: 8553030 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]